Explore 2025's groundbreaking scientific discoveries: the MoM-z14 galaxy, personalised CRISPR therapy, regenerative medicine, ...
Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...
Across sectors, tech majors worldwide blurred the line between experimental and practical, pushing the world into a new phase ...
Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, including heart disease and fatty liver disease (MASLD).
All investors would love to get rich overnight. As anyone who's been in the market for a while can attest, however, that's ...
It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...
Against this backdrop, a research team led by Dr. Guozhang Kang and Dr. Gezi Li from Henan Agricultural University, China, ...
The global prime editing and CRISPR market size was US$ 3,194.2 million in 2021. The global prime editing and CRISPR market is forecast to grow to US$ 17,618.4 million by 2030 by registering a ...
Zacks Small Cap Research on MSN

DYAI: Layers of commercialization agreements

The new arrangements were all announced in December and include a development and commercialization agreement signed with BRIG BIO, a commercial partnership with Opes Diagnostics and an expansion of ...
Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...
Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...
Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.